271 related articles for article (PubMed ID: 30019510)
1. Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.
Binder C; Matthes KL; Korol D; Rohrmann S; Moch H
Cancer Med; 2018 Sep; 7(9):4814-4824. PubMed ID: 30019510
[TBL] [Abstract][Full Text] [Related]
2. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J
Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354
[TBL] [Abstract][Full Text] [Related]
3. Time trends in survival from cancer of unknown primary: small steps forward.
Riihimäki M; Hemminki A; Sundquist K; Hemminki K
Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.
Ross JS; Sokol ES; Moch H; Mileshkin L; Baciarello G; Losa F; Beringer A; Thomas M; Elvin JA; Ngo N; Jin DX; Krämer A
Oncologist; 2021 Mar; 26(3):e394-e402. PubMed ID: 33219618
[TBL] [Abstract][Full Text] [Related]
5. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
[TBL] [Abstract][Full Text] [Related]
6. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
Randén M; Rutqvist LE; Johansson H
Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
[TBL] [Abstract][Full Text] [Related]
7. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
Shu X; Sundquist K; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
[TBL] [Abstract][Full Text] [Related]
8. Adherence to the World Cancer Research Fund and the American Institute for Cancer Research lifestyle recommendations for cancer prevention and Cancer of Unknown Primary risk.
Hermans KEPE; van den Brandt PA; Loef C; Jansen RLH; Schouten LJ
Clin Nutr; 2022 Feb; 41(2):526-535. PubMed ID: 35026689
[TBL] [Abstract][Full Text] [Related]
9. Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.
Pavlidis N; Rassy E; Smith-Gagen J
Int J Cancer; 2020 Mar; 146(6):1490-1498. PubMed ID: 31144291
[TBL] [Abstract][Full Text] [Related]
10. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
[TBL] [Abstract][Full Text] [Related]
11. Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.
Boscolo Bielo L; Belli C; Crimini E; Repetto M; Ascione L; Pellizzari G; Santoro C; Fuorivia V; Barberis M; Fusco N; Rocco EG; Curigliano G
Oncologist; 2024 Jun; 29(6):504-510. PubMed ID: 38520742
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait.
Huey RW; Makawita S; Xiao L; Matamoros A; Estrella JS; Overman MJ; Varadhachary GR; Raghav K
BMC Cancer; 2019 Oct; 19(1):965. PubMed ID: 31623602
[TBL] [Abstract][Full Text] [Related]
13. Real-world data analysis of patients with cancer of unknown primary.
Kang S; Jeong JH; Yoon S; Yoo C; Kim KP; Cho H; Ryoo BY; Jung J; Kim JE
Sci Rep; 2021 Nov; 11(1):23074. PubMed ID: 34845302
[TBL] [Abstract][Full Text] [Related]
14. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
[TBL] [Abstract][Full Text] [Related]
15. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
16. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
[TBL] [Abstract][Full Text] [Related]
17. The currently declining incidence of cancer of unknown primary.
Rassy E; Pavlidis N
Cancer Epidemiol; 2019 Aug; 61():139-141. PubMed ID: 31254795
[TBL] [Abstract][Full Text] [Related]
18. Familial Risk in Patients With Carcinoma of Unknown Primary.
Samadder NJ; Smith KR; Hanson H; Pimentel R; Wong J; Boucher K; Akerley W; Gilcrease G; Ulrich CM; Burt RW; Curtin K
JAMA Oncol; 2016 Mar; 2(3):340-6. PubMed ID: 26863281
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immune profiling for cancer of unknown primary site.
Haratani K; Hayashi H; Takahama T; Nakamura Y; Tomida S; Yoshida T; Chiba Y; Sawada T; Sakai K; Fujita Y; Togashi Y; Tanizaki J; Kawakami H; Ito A; Nishio K; Nakagawa K
J Immunother Cancer; 2019 Sep; 7(1):251. PubMed ID: 31519206
[TBL] [Abstract][Full Text] [Related]
20. Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
Brustugun OT; Helland Å
Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
